Last reviewed · How we verify

Nitrous Oxide/Oxygen — Competitive Intelligence Brief

Nitrous Oxide/Oxygen (Nitrous Oxide/Oxygen) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inhalational anesthetic and analgesic gas. Area: Anesthesia and Sedation.

marketed Inhalational anesthetic and analgesic gas NMDA receptor antagonist; GABAergic potentiator Anesthesia and Sedation Small molecule Live · refreshed every 30 min

Target snapshot

Nitrous Oxide/Oxygen (Nitrous Oxide/Oxygen) — Nationwide Children's Hospital. Nitrous oxide acts as a dissociative anesthetic and analgesic by modulating NMDA receptor activity and enhancing inhibitory neurotransmission in the central nervous system.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Nitrous Oxide/Oxygen TARGET Nitrous Oxide/Oxygen Nationwide Children's Hospital marketed Inhalational anesthetic and analgesic gas NMDA receptor antagonist; GABAergic potentiator

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inhalational anesthetic and analgesic gas class)

  1. Nationwide Children's Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Nitrous Oxide/Oxygen — Competitive Intelligence Brief. https://druglandscape.com/ci/nitrous-oxide-oxygen. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: